HCA Florida Pasadena Hospital recognized with 5 Five-Star quality achievements from Healthgrades

St. Petersburg, FL — HCA Florida Pasadena Hospital announced today that is has received Five-Star quality recognitions for specialty care in the Treatment of Heart Failure, Total Hip Replacement, Hip Fracture Treatment, Treatment of Sepsis and Treatment of Diabetic Hospitalizations. These distinctions reflect Pasadena Hospital’s outstanding clinical performance in research released by Healthgrades, the leading resource consumers use to find a doctor or hospital.

“Our team continues to show up each day committed to providing our patients with high quality compassionate care,” said CEO Brent Burish. “This research supports our commitment to following the latest guidelines and investing in the latest technology and training to ensure optimal outcomes for the patients we serve.”

The Healthgrades report evaluates hospitals solely on clinical outcomes: risk-adjusted mortality and complications. By focusing on what matters most, patient outcomes, the Healthgrades ratings provide critical feedback for both patients and hospitals. The 2024 hospital assessment evaluated patient mortality and complication rates for 35 common conditions and procedures at approximately 4,500 hospitals nationwide.

“Healthgrades congratulates HCA Florida Pasadena Hospital for being a national leader and demonstrating a deep commitment to providing high-quality care to all patients,” said Brad Bowman, MD, chief medical officer and head of data science at Healthgrades. “As health systems nationwide endeavor to elevate the quality of care, these elite facilities provide a roadmap for success. We commend Pasadena Hospital for their dedication to excellence in patient care.”

The awards included:

Cardiac

• Five-Star Recipient for Treatment of Heart Failure for 2 Years in a Row (2023-2024)

Orthopedics

• Five-Star Recipient for Total Hip Replacement in 2024
• Five-Star Recipient for Hip Fracture in 2024

Critical Care

• Five-Star Recipient for Treatment of Sepsis for 4 Years in Row (2021-2024)
• Five-Star Recipient for Treatment of Diabetic Hospitalizations for 2 Years in a Row (2023-2024)